Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine for Prevention of Atrial Fibrillation After Cardiac Surgery
NCT04224545Phase 4Completed
- Sponsor
- Bakulev National Medical Research Center for Cardiovascular Surgery
- Start
- Dec 2019
- Primary completion
- Aug 2022
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of colchicine in Atrial fibrillation (AFib), sponsored by Bakulev National Medical Research Center for Cardiovascular Surgery. Started Dec 2019; status: completed.
02
Drugs
colchicine
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT04224545.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04224545.